Quantcast
Last updated on April 17, 2014 at 11:16 EDT

Latest Antibody Stories

2014-03-10 23:24:13

Xtalks presents an exciting live webinar on Wednesday, March 26, 2014 at 11:00 EDT (15:00 GMT). Join keynote speaker Dr. Dhaval Shah, Assistant Professor at the Department of Pharmaceutical Sciences, University at Buffalo, for a one-hour presentation to learn Using PK/PD modeling for Antibody Drug Conjugate Translation. Toronto, Canada (PRWEB) March 10, 2014 Antibody Drug Conjugates (ADCs) are at the forefront of the therapeutic market. The first therapeutic antibody was approved by the...

2014-03-10 08:29:22

- Phase 2 Clinical Trial in aHUS and Other TMAs Expected to Begin Next Quarter - SEATTLE, March 10, 2014 /PRNewswire/ -- Omeros Corporation (NASDAQ: OMER) today announced positive data using OMS721, the lead human monoclonal antibody in Omeros' mannan-binding lectin-associated serine protease-2 (MASP-2) program, in ex vivo studies of endothelial activation relevant to the pathophysiology of human atypical hemolytic uremic syndrome (aHUS), a form of thrombotic microangiopathy (TMA)....

2014-03-07 08:21:14

DUBLIN, Mar. 07, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/cl5vpz/antibody_target ) has announced the addition of the "Concise Database for Antibody Target, Technology & Pipeline: 1-Year Subscription" subscription to their offering. (Logo:http://photos.prnewswire.com/prnh/20130307/600769) Subscription to La Merie Publishing's proprietary Antibody Database provides online access to information about more than 2,400 project entries for...

2014-03-06 23:04:31

Catalent Pharma Solutions, the global leader in advanced delivery technologies and development solutions for drug, biologic and consumer health products, today announced an agreement with the Center for iPS Cell Research and Application (CiRA) at Kyoto University in Japan to make a major advancement toward one of the first regenerative human therapies with induced pluripotent stem (iPS) cells applicable to humans. Somerset, NJ (PRWEB) March 06, 2014 Catalent Pharma Solutions, the global...

2014-03-06 12:26:44

DUBLIN, Mar. 06, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/njgf7d/research_report ) has announced the addition of the "Concise Analysis of the International and China Monoclonal Antibody Industry" report to their offering. (Logo:http://photos.prnewswire.com/prnh/20130307/600769) Monoclonal antibody still belongs to high-end products in China market, which mainly depends on import. In 2012, the market scale of monoclonal antibody was only over...

2014-03-05 08:29:20

DUBLIN, March 5, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/r8hfhg/fc_protein_and) has announced the addition of the "Fc Protein and Glycoengineered Antibodies Market" [http://www.researchandmarkets.com/research/r8hfhg/fc_protein_and ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Engineered antibodies are antibody based therapeutics, which are gaining increasing attention from...

2014-03-05 04:22:20

DUBLIN, March 5, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/885sfr/bispecific ) has announced the addition of the "Concise Analysis of the International Bispecific Antibody Therapeutics Market" [http://www.researchandmarkets.com/research/885sfr/bispecific ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Antibody based therapeutics are the fastest growing segment of the drugs and...

2014-02-27 18:33:27

By re-engineering a tiny chain of amino acids in one type of dengue virus, Ralph Baric and Aravinda de Silva discover a new path toward solving the dengue vaccine dilemma. The research has the potential to transform vaccine development for other diseases, including SARS and HIV. Creating a vaccine that protects people from all four types of dengue virus has frustrated scientists for decades. But researchers at the University of North Carolina have discovered a new target for human...

2014-02-21 16:23:07

PHILADELPHIA, Feb. 21, 2014 /PRNewswire-USNewswire/ -- An antibody found in the blood of people with multiple sclerosis (MS) may be present long before the onset of the disease and its symptoms, according to a study released today that will be presented at the American Academy of Neurology's 66th Annual Meeting in Philadelphia, April 26 to May 3, 2014. "If our results can be replicated in larger populations, our findings may help to detect MS earlier in a subgroup of patients," said...

Studies Of Cow Antibodies Help Scientists Understand How Our Own Bodies Work
2014-02-19 12:20:46

American Institute of Physics Understanding how antibodies work is important for designing new vaccines to fight infectious diseases and certain types of cancer and for treating disorders of the immune system in animals and humans. In research to be presented at the 58th Annual Biophysical Society Meeting, taking place in San Francisco from Feb. 15-19, Dr. Damian Ekiert, who is now at the University of California, San Francisco, will describe research he conducted as part of a team of...